Rate My Professor Lianne Parkin

Professor Lianne Parkin, MB ChB, DipObst, DPH, PhD, FAFPHM, serves as a Professor in the Department of Public Health (Dunedin) within the University of Otago's Dunedin School of Medicine. She earned her medical degree (MB ChB) and Postgraduate Diploma in Obstetrics (DipObst) from the University of Otago. Following this, she trained and worked for several years as a general practitioner in New Zealand and Australia. She then completed further training in Public Health Medicine and obtained her PhD from the University of Otago in 2008, focusing on pharmacoepidemiology with a thesis on risk factors for venous thromboembolism. Currently, she holds key leadership positions as Director of the New Zealand Pharmacovigilance Centre and Lead Investigator of the Pharmacoepidemiology Research Network Core Academic Group.

Professor Parkin's research centers on epidemiology and pharmacoepidemiology, leveraging routinely collected electronic health and pharmaceutical dispensing data to investigate the utilization and safety of medicines and medical devices, with a particular emphasis on medicines use during pregnancy and venous thromboembolism. Her contributions include studies on smoking cessation pharmacotherapies, opioid use, and congenital malformations in pregnancy. Key publications are Robijn et al. (2025), 'Effectiveness of smoking cessation pharmacotherapies during pregnancy: A multi-national population-based study' in Addiction; Tran et al. (2025), 'Risk of major congenital malformations following prenatal exposure to smoking cessation medicines' in JAMA Internal Medicine; Brett et al. (2025), 'Global trends in analgesic opioid use in pregnancy: A retrospective cohort study' in Anesthesiology; and Robijn et al. (2024), 'Smoking cessation pharmacotherapy use in pregnancy' in JAMA Network Open. Additional works address metformin adherence in type 2 diabetes, antidepressant dispensing around pregnancy, and insulin pump utilization disparities. She delivered her Inaugural Professorial Lecture on 14 September 2023.